Pacer Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119M Buy
246,675
+145,335
+143% +$38.6M 0.3% 79
2026
Q1
$11.1M Sell
101,340
-286,738
-74% -$40.8M 0.03% 432
2025
Q4
$64.6M Sell
388,078
-125,074
-24% -$20.9M 0.16% 139
2025
Q3
$100M Buy
+513,152
New +$84.4M 0.25% 83
2025
Q2
Sell
-501,677
Closed -$29.9M 3616
2025
Q1
$29.9M Buy
+501,677
New +$46.4M 0.07% 237

Other funds holding ALAB

Pacer Advisors's ALAB Position: Q2 2026 in Review

Pacer Advisors increased its Astera Labs (ALAB) stake by 143% in Q2 2026, buying an estimated $38.6M and bringing the position to 246,675 shares worth $119M. The position accounts for 0.3% of the portfolio, ranked #79.

Pacer Advisors first reported a position in ALAB in Q1 2025 and has held it in 5 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Pacer Advisors held 246,675 shares of Astera Labs worth $119M as of Q2 2026.
  • Pacer Advisors bought 145,335 Astera Labs shares in Q2 2026, an estimated $38.6M.
  • Astera Labs made up 0.3% of Pacer Advisors's portfolio in Q2 2026, its #79 holding.
  • Pacer Advisors first reported a position in Astera Labs in Q1 2025 and has held it in 5 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.